Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The field of bleeding disorders has seen monumental transformation. For many pat...
Antibody-drug conjugates (ADCs) constitute a rapidly evolving class of targeted ...
In this Thought Leader article, Campbell Bunce, PhD, CSO of Abzena writes about ...
Antibody-drug conjugates (ADCs) have evolved from an elegant scientific concept ...
Today’s organoid companies underscore proof points in the ability to model compl...
In this Point of View column, Mike Garrett, CEO of Taconic Biosciences, explores...
Researchers developed novel, first-in-class drugs that inhibit both HIF-1 and HI...
Researchers developed a method to assemble n-doped poly(benzodifurandione) (n-PB...
For the genomics community February means the season of big announcements as the...
The past year marked a proverbial inflection point for organoid models designed ...
GeneLock is a cybersecurity-inspired technology that protects genetic material d...
Inhibiting AhR, a xenobiotic sensor protein, lifts a molecular brake on axon reg...
PRISM ALS aims to develop, evaluate, and make available a diverse panel of well-...
A whole exome sequencing study in women carrying a pathogenic BRCA1 mutation fou...
Many new personalized cancer vaccines (PVCs) platforms are at or near the clinic...
Despite significant advances in genome editing technologies over the past decade...
